Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Steven Abman to Nitric Oxide

This is a "connection" page, showing publications Steven Abman has written about Nitric Oxide.

 
Connection Strength
  
 
 
12.138
  
  1. Mandell E, Kinsella JP, Abman SH. Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 2021 03; 56(3):661-669.
    View in: PubMed
    Score: 0.514
  2. Chandrasekharan P, Lakshminrusimha S, Abman SH. When to say no to inhaled nitric oxide in neonates? Semin Fetal Neonatal Med. 2021 04; 26(2):101200.
    View in: PubMed
    Score: 0.510
  3. Lakshminrusimha S, Kinsella JP, Krishnan US, Van Meurs K, Edwards EM, Bhatt DR, Chandrasekharan P, Oei JL, Manja V, Ramanathan R, Abman SH. Just Say No to iNO in Preterms-Really? J Pediatr. 2020 03; 218:243-252.
    View in: PubMed
    Score: 0.472
  4. Kinsella JP, Steinhorn RH, Krishnan US, Feinstein JA, Adatia I, Austin ED, Rosenzweig EB, Everett AD, Fineman JR, Hanna BD, Hopper RK, Humpl T, Ivy DD, Keller RL, Mullen MP, Raj JU, Wessel DL, Abman SH. Recommendations for the Use of Inhaled Nitric Oxide Therapy in Premature Newborns with Severe Pulmonary Hypertension. J Pediatr. 2016 Mar; 170:312-4.
    View in: PubMed
    Score: 0.358
  5. Kinsella JP, Cutter GR, Steinhorn RH, Nelin LD, Walsh WF, Finer NN, Abman SH. Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns. J Pediatr. 2014 Dec; 165(6):1104-1108.e1.
    View in: PubMed
    Score: 0.325
  6. Abman SH. Inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Handb Exp Pharmacol. 2013; 218:257-76.
    View in: PubMed
    Score: 0.292
  7. Tourneux P, Markham N, Seedorf G, Balasubramaniam V, Abman SH. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats. Am J Physiol Lung Cell Mol Physiol. 2009 Dec; 297(6):L1103-11.
    View in: PubMed
    Score: 0.234
  8. Fujinaga H, Baker CD, Ryan SL, Markham NE, Seedorf GJ, Balasubramaniam V, Abman SH. Hyperoxia disrupts vascular endothelial growth factor-nitric oxide signaling and decreases growth of endothelial colony-forming cells from preterm infants. Am J Physiol Lung Cell Mol Physiol. 2009 Dec; 297(6):L1160-9.
    View in: PubMed
    Score: 0.232
  9. Muehlethaler V, Kunig AM, Seedorf G, Balasubramaniam V, Abman SH. Impaired VEGF and nitric oxide signaling after nitrofen exposure in rat fetal lung explants. Am J Physiol Lung Cell Mol Physiol. 2008 Jan; 294(1):L110-20.
    View in: PubMed
    Score: 0.204
  10. Tang JR, Seedorf G, Balasubramaniam V, Maxey A, Markham N, Abman SH. Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition. Am J Physiol Lung Cell Mol Physiol. 2007 Nov; 293(5):L1271-80.
    View in: PubMed
    Score: 0.202
  11. Gien J, Seedorf GJ, Balasubramaniam V, Markham N, Abman SH. Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling. Am J Respir Crit Care Med. 2007 Dec 01; 176(11):1146-53.
    View in: PubMed
    Score: 0.202
  12. Kinsella JP, Abman SH. Inhaled nitric oxide in the premature newborn. J Pediatr. 2007 Jul; 151(1):10-5.
    View in: PubMed
    Score: 0.199
  13. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med. 2006 Jul 27; 355(4):354-64.
    View in: PubMed
    Score: 0.187
  14. Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, Abman SH. Inhaled NO restores lung structure in eNOS-deficient mice recovering from neonatal hypoxia. Am J Physiol Lung Cell Mol Physiol. 2006 Jul; 291(1):L119-27.
    View in: PubMed
    Score: 0.181
  15. Balasubramaniam V, Maxey AM, Fouty BW, Abman SH. Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol. 2006 Jun; 290(6):L1111-6.
    View in: PubMed
    Score: 0.180
  16. Balasubramaniam V, Maxey A, Abman S. Inhaled nitric oxide reverses hypoxia induced lung hypoplasia in endothelial nitric oxide synthase-deficient mice. Chest. 2005 Dec; 128(6 Suppl):613S-614S.
    View in: PubMed
    Score: 0.179
  17. Kinsella JP, Abman SH. Inhaled nitric oxide therapy in children. Paediatr Respir Rev. 2005 Sep; 6(3):190-8.
    View in: PubMed
    Score: 0.176
  18. Deruelle P, Grover TR, Abman SH. Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep. Am J Physiol Lung Cell Mol Physiol. 2005 Nov; 289(5):L798-806.
    View in: PubMed
    Score: 0.173
  19. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res. 2005 Jul; 58(1):22-9.
    View in: PubMed
    Score: 0.172
  20. Kinsella JP, Ivy DD, Abman SH. Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension. Semin Perinatol. 2005 Apr; 29(2):123-8.
    View in: PubMed
    Score: 0.171
  21. Mourani PM, Ivy DD, Gao D, Abman SH. Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2004 Nov 01; 170(9):1006-13.
    View in: PubMed
    Score: 0.161
  22. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol. 2004 Aug; 287(2):L344-51.
    View in: PubMed
    Score: 0.159
  23. Ivy DD, Parker D, Doran A, Parker D, Kinsella JP, Abman SH. Acute hemodynamic effects and home therapy using a novel pulsed nasal nitric oxide delivery system in children and young adults with pulmonary hypertension. Am J Cardiol. 2003 Oct 01; 92(7):886-90.
    View in: PubMed
    Score: 0.154
  24. Kinsella JP, Parker TA, Ivy DD, Abman SH. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia. J Pediatr. 2003 Apr; 142(4):397-401.
    View in: PubMed
    Score: 0.148
  25. Kinsella JP, Griebel J, Schmidt JM, Abman SH. Use of inhaled nitric oxide during interhospital transport of newborns with hypoxemic respiratory failure. Pediatrics. 2002 Jan; 109(1):158-61.
    View in: PubMed
    Score: 0.136
  26. Sch?fer M, Frank BS, Ivy DD, Abman SH, Stenmark KR, Mitchell MB, Browne LP, Barker AJ, Hunter KS, Kheyfets V, Miller-Reed K, Ing R, Morgan GJ, Truong U. Short-Term Effects of Inhaled Nitric Oxide on Right Ventricular Flow Hemodynamics by 4-Dimensional-Flow Magnetic Resonance Imaging in Children With Pulmonary Arterial Hypertension. J Am Heart Assoc. 2021 04 20; 10(8):e020548.
    View in: PubMed
    Score: 0.129
  27. Kinsella JP, Abman SH. Inhaled nitric oxide: current and future uses in neonates. Semin Perinatol. 2000 Dec; 24(6):387-95.
    View in: PubMed
    Score: 0.126
  28. Kinsella JP, Abman SH. Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia. J Pediatr. 2000 Jun; 136(6):717-26.
    View in: PubMed
    Score: 0.122
  29. Abman SH. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr Rev. 1999 Nov; 20(11):e103-9.
    View in: PubMed
    Score: 0.117
  30. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet. 1999 Sep 25; 354(9184):1061-5.
    View in: PubMed
    Score: 0.116
  31. Kinsella JP, Parker TA, Galan H, Sheridan BC, Abman SH. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome. Chest. 1999 Jul; 116(1 Suppl):15S-16S.
    View in: PubMed
    Score: 0.114
  32. Dobyns EL, Cornfield DN, Anas NG, Fortenberry JD, Tasker RC, Lynch A, Liu P, Eells PL, Griebel J, Baier M, Kinsella JP, Abman SH. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr. 1999 Apr; 134(4):406-12.
    View in: PubMed
    Score: 0.113
  33. Kinsella JP, Parker TA, Galan H, Sheridan BC, Abman SH. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome. Am J Respir Crit Care Med. 1999 Apr; 159(4 Pt 1):1220-7.
    View in: PubMed
    Score: 0.113
  34. Kinsella JP, Abman SH. Recent developments in inhaled nitric oxide therapy of the newborn. Curr Opin Pediatr. 1999 Apr; 11(2):121-5.
    View in: PubMed
    Score: 0.113
  35. Ziegler JW, Ivy DD, Wiggins JW, Kinsella JP, Clarke WR, Abman SH. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Am J Respir Crit Care Med. 1998 Nov; 158(5 Pt 1):1388-95.
    View in: PubMed
    Score: 0.109
  36. Ivy DD, Griebel JL, Kinsella JP, Abman SH. Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr. 1998 Sep; 133(3):453-6.
    View in: PubMed
    Score: 0.108
  37. Ivy DD, Ziegler JW, Kinsella JP, Wiggins JW, Abman SH. Hemodynamic effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension. Chest. 1998 Jul; 114(1 Suppl):17S.
    View in: PubMed
    Score: 0.107
  38. Kinsella JP, Abman SH. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group. Chest. 1998 Jul; 114(1 Suppl):100S.
    View in: PubMed
    Score: 0.107
  39. Abman SH, Kinsella JP. Inhaled nitric oxide therapy for pulmonary disease in pediatrics. Curr Opin Pediatr. 1998 Jun; 10(3):236-42.
    View in: PubMed
    Score: 0.106
  40. Parker TA, Kinsella JP, Abman SH. Response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: relationship to baseline oxygenation. J Perinatol. 1998 May-Jun; 18(3):221-5.
    View in: PubMed
    Score: 0.106
  41. Ziegler JW, Ivy DD, Fox JJ, Kinsella JP, Clarke WR, Abman SH. Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med. 1998 Apr; 157(4 Pt 1):1104-10.
    View in: PubMed
    Score: 0.105
  42. Ivy DD, Kinsella JP, Ziegler JW, Abman SH. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease. J Thorac Cardiovasc Surg. 1998 Apr; 115(4):875-82.
    View in: PubMed
    Score: 0.105
  43. Kinsella JP, Abman SH. Controversies in the use of inhaled nitric oxide therapy in the newborn. Clin Perinatol. 1998 Mar; 25(1):203-17.
    View in: PubMed
    Score: 0.104
  44. Kinsella JP, Abman SH. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn. Eur J Pediatr. 1998 Jan; 157 Suppl 1:S28-30.
    View in: PubMed
    Score: 0.103
  45. Abman SH. Role of inhaled nitric oxide in treatment of neonatal pulmonary hypertension. Zhongguo Yao Li Xue Bao. 1997 Nov; 18(6):542-5.
    View in: PubMed
    Score: 0.102
  46. Kinsella JP, Abman SH. Inhaled nitric oxide in the premature infant: animal models and clinical experience. Semin Perinatol. 1997 Oct; 21(5):418-25.
    View in: PubMed
    Score: 0.101
  47. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 1997 Jul; 131(1 Pt 1):55-62.
    View in: PubMed
    Score: 0.100
  48. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res. 1997 Apr; 41(4 Pt 1):457-63.
    View in: PubMed
    Score: 0.098
  49. Parker TA, Ivy DD, Kinsella JP, Torielli F, Ruyle SZ, Thilo EH, Abman SH. Combined therapy with inhaled nitric oxide and intravenous prostacyclin in an infant with alveolar-capillary dysplasia. Am J Respir Crit Care Med. 1997 Feb; 155(2):743-6.
    View in: PubMed
    Score: 0.097
  50. Fox JJ, Ziegler JW, Ivy DD, Halbower AC, Kinsella JP, Abman SH. Role of nitric oxide and cGMP system in regulation of ductus arteriosus tone in ovine fetus. Am J Physiol. 1996 Dec; 271(6 Pt 2):H2638-45.
    View in: PubMed
    Score: 0.096
  51. Cornfield DN, Abman SH. Inhalational nitric oxide in pulmonary parenchymal and vascular disease. J Lab Clin Med. 1996 Jun; 127(6):530-9.
    View in: PubMed
    Score: 0.092
  52. Kinsella JP, Abman SH. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy. J Perinatol. 1996 Mar-Apr; 16(2 Pt 2 Su):S24-7.
    View in: PubMed
    Score: 0.091
  53. Ivy DD, Kinsella JP, Wolfe RR, Abman SH. Atrial natriuretic peptide and nitric oxide in children with pulmonary hypertension after surgical repair of congenital heart disease. Am J Cardiol. 1996 Jan 01; 77(1):102-5.
    View in: PubMed
    Score: 0.090
  54. Abman SH, Kinsella JP. Inhaled nitric oxide for persistent pulmonary hypertension of the newborn: the physiology matters! Pediatrics. 1995 Dec; 96(6):1153-5.
    View in: PubMed
    Score: 0.089
  55. Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, Stenmark KR, Steinhorn R, Th?baud B, Fineman JR, Kuehne T, Feinstein JA, Friedberg MK, Earing M, Barst RJ, Keller RL, Kinsella JP, Mullen M, Deterding R, Kulik T, Mallory G, Humpl T, Wessel DL. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society. Circulation. 2015 Nov 24; 132(21):2037-99.
    View in: PubMed
    Score: 0.089
  56. Mourani PM, Abman SH. Pulmonary Hypertension and Vascular Abnormalities in Bronchopulmonary Dysplasia. Clin Perinatol. 2015 Dec; 42(4):839-55.
    View in: PubMed
    Score: 0.088
  57. Kinsella JP, Torielli F, Ziegler JW, Ivy DD, Abman SH. Dipyridamole augmentation of response to nitric oxide. Lancet. 1995 Sep 02; 346(8975):647-8.
    View in: PubMed
    Score: 0.088
  58. Rosenberg AA, Kinsella JP, Abman SH. Cerebral hemodynamics and distribution of left ventricular output during inhalation of nitric oxide. Crit Care Med. 1995 Aug; 23(8):1391-7.
    View in: PubMed
    Score: 0.087
  59. Ziegler JW, Ivy DD, Kinsella JP, Abman SH. The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation. Clin Perinatol. 1995 Jun; 22(2):387-403.
    View in: PubMed
    Score: 0.086
  60. Kinsella JP, Abman SH. Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr. 1995 Jun; 126(6):853-64.
    View in: PubMed
    Score: 0.086
  61. Kinsella JP, Schmidt JM, Griebel J, Abman SH. Inhaled nitric oxide treatment for stabilization and emergency medical transport of critically ill newborns and infants. Pediatrics. 1995 May; 95(5):773-6.
    View in: PubMed
    Score: 0.086
  62. Abman SH, Kinsella JP. Inhaled nitric oxide therapy of pulmonary hypertension and respiratory failure in premature and term neonates. Adv Pharmacol. 1995; 34:457-74.
    View in: PubMed
    Score: 0.084
  63. Kinsella JP, Ivy DD, Abman SH. Ontogeny of NO activity and response to inhaled NO in the developing ovine pulmonary circulation. Am J Physiol. 1994 Nov; 267(5 Pt 2):H1955-61.
    View in: PubMed
    Score: 0.083
  64. Kinsella JP, Ivy DD, Abman SH. Inhaled nitric oxide improves gas exchange and lowers pulmonary vascular resistance in severe experimental hyaline membrane disease. Pediatr Res. 1994 Sep; 36(3):402-8.
    View in: PubMed
    Score: 0.082
  65. Ivy DD, Wiggins JW, Badesch DB, Kinsella JP, Kelminson LL, Abman SH. Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension. Am J Cardiol. 1994 Aug 15; 74(4):414-6.
    View in: PubMed
    Score: 0.082
  66. Abman SH. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr Opin Pediatr. 1994 Jun; 6(3):239-47.
    View in: PubMed
    Score: 0.081
  67. Abman SH, Griebel JL, Parker DK, Schmidt JM, Swanton D, Kinsella JP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr. 1994 Jun; 124(6):881-8.
    View in: PubMed
    Score: 0.081
  68. Kinsella JP, Abman SH. Efficacy of inhalational nitric oxide therapy in the clinical management of persistent pulmonary hypertension of the newborn. Chest. 1994 Mar; 105(3 Suppl):92S-94S.
    View in: PubMed
    Score: 0.079
  69. Gadhia MM, Cutter GR, Abman SH, Kinsella JP. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure. J Pediatr. 2014 Apr; 164(4):744-8.
    View in: PubMed
    Score: 0.078
  70. Abman SH, Kinsella JP, Schaffer MS, Wilkening RB. Inhaled nitric oxide in the management of a premature newborn with severe respiratory distress and pulmonary hypertension. Pediatrics. 1993 Oct; 92(4):606-9.
    View in: PubMed
    Score: 0.077
  71. Klinger JR, Abman SH, Gladwin MT. Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013 Sep 15; 188(6):639-46.
    View in: PubMed
    Score: 0.077
  72. Kinsella JP, Abman SH. Methaemoglobin during nitric oxide therapy with high-frequency ventilation. Lancet. 1993 Sep 04; 342(8871):615.
    View in: PubMed
    Score: 0.076
  73. Kinsella JP, Neish SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide. J Pediatr. 1993 Jul; 123(1):103-8.
    View in: PubMed
    Score: 0.076
  74. Kinsella JP, Abman SH. Inhalational nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatrics. 1993 May; 91(5):997-8.
    View in: PubMed
    Score: 0.075
  75. Kinsella JP, Toews WH, Henry D, Abman SH. Selective and sustained pulmonary vasodilation with inhalational nitric oxide therapy in a child with idiopathic pulmonary hypertension. J Pediatr. 1993 May; 122(5 Pt 1):803-6.
    View in: PubMed
    Score: 0.075
  76. McQueston JA, Cornfield DN, McMurtry IF, Abman SH. Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation. Am J Physiol. 1993 Mar; 264(3 Pt 2):H865-71.
    View in: PubMed
    Score: 0.074
  77. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 03; 340(8823):819-20.
    View in: PubMed
    Score: 0.072
  78. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol. 1992 Sep; 263(3 Pt 2):H875-80.
    View in: PubMed
    Score: 0.071
  79. Rozance PJ, Seedorf GJ, Brown A, Roe G, O'Meara MC, Gien J, Tang JR, Abman SH. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol. 2011 Dec; 301(6):L860-71.
    View in: PubMed
    Score: 0.066
  80. Chester M, Seedorf G, Tourneux P, Gien J, Tseng N, Grover T, Wright J, Stasch JP, Abman SH. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2011 Nov; 301(5):L755-64.
    View in: PubMed
    Score: 0.066
  81. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurtry IF. Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am J Physiol. 1991 Apr; 260(4 Pt 1):L280-5.
    View in: PubMed
    Score: 0.065
  82. Abman SH, Chatfield BA, Hall SL, McMurtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990 Dec; 259(6 Pt 2):H1921-7.
    View in: PubMed
    Score: 0.063
  83. Abman SH. Pulmonary hypertension in children: a historical overview. Pediatr Crit Care Med. 2010 Mar; 11(2 Suppl):S4-9.
    View in: PubMed
    Score: 0.060
  84. Watson RS, Clermont G, Kinsella JP, Kong L, Arendt RE, Cutter G, Linde-Zwirble WT, Abman SH, Angus DC. Clinical and economic effects of iNO in premature newborns with respiratory failure at 1 year. Pediatrics. 2009 Nov; 124(5):1333-43.
    View in: PubMed
    Score: 0.058
  85. Chester M, Tourneux P, Seedorf G, Grover TR, Gien J, Abman SH. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2009 Aug; 297(2):L318-25.
    View in: PubMed
    Score: 0.057
  86. Abman SH. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology. 2007; 91(4):283-90.
    View in: PubMed
    Score: 0.050
  87. Parker TA, Roe G, Grover TR, Abman SH. Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol. 2006 Nov; 291(5):L976-82.
    View in: PubMed
    Score: 0.046
  88. Kinsella JP, Parker TA, Davis JM, Abman SH. Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med. 2005 Sep 15; 172(6):745-9.
    View in: PubMed
    Score: 0.043
  89. Parker TA, Grover TR, Kinsella JP, Falck JR, Abman SH. Inhibition of 20-HETE abolishes the myogenic response during NOS antagonism in the ovine fetal pulmonary circulation. Am J Physiol Lung Cell Mol Physiol. 2005 Aug; 289(2):L261-7.
    View in: PubMed
    Score: 0.043
  90. Deruelle P, Grover TR, Storme L, Abman SH. Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus. Am J Physiol Lung Cell Mol Physiol. 2005 Apr; 288(4):L727-33.
    View in: PubMed
    Score: 0.042
  91. Abman SH. Neonatal pulmonary hypertension: a physiologic approach to treatment. Pediatr Pulmonol Suppl. 2004; 26:127-8.
    View in: PubMed
    Score: 0.039
  92. Dyess NF, Palmer C, Soll RF, Clark RH, Abman SH, Kinsella JP. Practices and Outcomes from a Prospective, Multicenter Registry for Preterm Newborns with Pulmonary Hypertension. J Pediatr. 2023 11; 262:113614.
    View in: PubMed
    Score: 0.038
  93. Abman SH. Monitoring cardiovascular function in infants with chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed. 2002 Jul; 87(1):F15-8.
    View in: PubMed
    Score: 0.035
  94. Cookson MW, Abman SH, Kinsella JP, Mandell EW. Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension. Semin Fetal Neonatal Med. 2022 08; 27(4):101367.
    View in: PubMed
    Score: 0.035
  95. Ivy D, McMurtry IF, Yanagisawa M, Gariepy CE, Le Cras TD, Gebb SA, Morris KG, Wiseman RC, Abman SH. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol. 2001 May; 280(5):L1040-8.
    View in: PubMed
    Score: 0.033
  96. Rairigh RL, Parker TA, Ivy DD, Kinsella JP, Fan ID, Abman SH. Role of inducible nitric oxide synthase in the pulmonary vascular response to birth-related stimuli in the ovine fetus. Circ Res. 2001 Apr 13; 88(7):721-6.
    View in: PubMed
    Score: 0.032
  97. G?thberg S, Parker TA, Abman SH, Kinsella JP. High-frequency oscillatory ventilation and partial liquid ventilation after acute lung injury in premature lambs with respiratory distress syndrome. Crit Care Med. 2000 Jul; 28(7):2450-6.
    View in: PubMed
    Score: 0.031
  98. Dobyns EL, Griebel J, Kinsella JP, Abman SH, Accurso FJ. Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn. Pediatr Pulmonol. 1999 Jul; 28(1):24-30.
    View in: PubMed
    Score: 0.029
  99. Storme L, Rairigh RL, Parker TA, Kinsella JP, Abman SH. Acute intrauterine pulmonary hypertension impairs endothelium-dependent vasodilation in the ovine fetus. Pediatr Res. 1999 Apr; 45(4 Pt 1):575-81.
    View in: PubMed
    Score: 0.028
  100. Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the Prevention and Treatment of Bronchopulmonary Dysplasia. Clin Perinatol. 2019 06; 46(2):291-310.
    View in: PubMed
    Score: 0.028
  101. Frank BS, Sch?fer M, Grenolds A, Ivy DD, Abman SH, Darst JR. Acute Vasoreactivity Testing during Cardiac Catheterization of Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. J Pediatr. 2019 05; 208:127-133.
    View in: PubMed
    Score: 0.028
  102. Abman SH. New developments in the pathogenesis and treatment of neonatal pulmonary hypertension. Pediatr Pulmonol Suppl. 1999; 18:201-4.
    View in: PubMed
    Score: 0.028
  103. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, Kinsella JP. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr. 1997 Jul; 131(1 Pt 1):70-5.
    View in: PubMed
    Score: 0.025
  104. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM, Abman SH. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest. 1997 Mar 15; 99(6):1179-86.
    View in: PubMed
    Score: 0.024
  105. Delaney C, Wright RH, Tang JR, Woods C, Villegas L, Sherlock L, Savani RC, Abman SH, Nozik-Grayck E. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension. Pediatr Res. 2015 Dec; 78(6):634-40.
    View in: PubMed
    Score: 0.022
  106. Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest. 1994 May; 93(5):2141-8.
    View in: PubMed
    Score: 0.020
  107. Wolf D, Tseng N, Seedorf G, Roe G, Abman SH, Gien J. Endothelin-1 decreases endothelial PPAR? signaling and impairs angiogenesis after chronic intrauterine pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2014 Feb 15; 306(4):L361-71.
    View in: PubMed
    Score: 0.019
  108. Acker SN, Seedorf GJ, Abman SH, Nozik-Grayck E, Partrick DA, Gien J. Pulmonary artery endothelial cell dysfunction and decreased populations of highly proliferative endothelial cells in experimental congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol. 2013 Dec; 305(12):L943-52.
    View in: PubMed
    Score: 0.019
  109. Kunig AM, Parker TA, Nogee LM, Abman SH, Kinsella JP. ABCA3 deficiency presenting as persistent pulmonary hypertension of the newborn. J Pediatr. 2007 Sep; 151(3):322-4.
    View in: PubMed
    Score: 0.013
  110. Fagan KA, Fouty BW, Tyler RC, Morris KG, Hepler LK, Sato K, LeCras TD, Abman SH, Weinberger HD, Huang PL, McMurtry IF, Rodman DM. The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest. 1999 Jan; 103(2):291-9.
    View in: PubMed
    Score: 0.007
  111. Ivy DD, Neish SR, Knudson OA, Nihill MR, Schaffer MS, Tyson RW, Abman SH, Shaffer EM, Valdes-Cruz L. Intravascular ultrasonic characteristics and vasoreactivity of the pulmonary vasculature in children with pulmonary hypertension. Am J Cardiol. 1998 Mar 15; 81(6):740-8.
    View in: PubMed
    Score: 0.007
  112. Kennaugh JM, Kinsella JP, Abman SH, Hernandez JA, Moreland SG, Rosenberg AA. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome. J Perinatol. 1997 Sep-Oct; 17(5):366-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)